MedPath

Evaluation of the effect of mesotherapy in the treatment of hair loss

Phase 3
Recruiting
Conditions
female androgenetic alopecia.
Androgenic alopecia
Registration Number
IRCT20181226042136N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
36
Inclusion Criteria

Having a female pattern hair loss
Do not use other hair loss treatments at the time of enrollment
Do not use temporary and permanent hair dye and curl or straighten hair
Do not use aspirin, warfarin, steroids, oral retinoids, hormones or cytotoxic drugs
Absence of pregnancy and lactation
Absence of high androgenic blood levels, irregular periods, acne and hirsutism, thromboembolic events, low ferritin blood levels and impaired TSH

Exclusion Criteria

Allergic reaction to the drug used
Failure to complete the course of treatment and failure to refer for follow-up, which results in a drawing on the case file or the patient
Local reactions such as abscesses, inflammation and cellulite at the injection site
The patient's decision not to participate in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath